Opportunities Preloader

Please Wait.....

Report

Latin America In-vitro Diagnostics Market Report and Forecast 2024-2032

Market Report I 2023-11-23 I 145 Pages I EMR Inc.

Latin America In-vitro Diagnostics Market Report and Forecast 2024-2032
Market Outlook
According to the report by Expert Market Research (EMR), the Latin America in-vitro diagnostics market is projected to grow at a CAGR of 17.9% between 2024 and 2032. Aided by the growing demand for early and precise disease diagnosis and the expanding applications of in-vitro diagnostics in various healthcare settings, the market is expected to grow significantly by 2032.
In-vitro diagnostics (IVD) are medical tests performed on samples such as blood or tissue, obtained from the human body. These tests are essential tools in healthcare as they aid in the detection of diseases, medical conditions, and infections, facilitating appropriate treatment and disease management. Apart from their diagnostic functions, IVDs also hold crucial roles in disease prevention, patient stratification, and monitoring drug response.
The increasing demand for early and accurate disease diagnosis is a major driver of the Latin America in-vitro diagnostics market growth. With a growing awareness of the importance of preventive healthcare and early intervention, there has been a significant shift towards the adoption of advanced diagnostic tests, leading to a surge in demand for IVD products. Additionally, the rising prevalence of chronic diseases and infectious conditions has further amplified the need for IVD, boosting the market expansion.
The broadening applications of in-vitro diagnostics in various healthcare settings also significantly contribute to the Latin America in-vitro diagnostics market demand. In clinical laboratories, IVDs are used for a wide range of tests, from basic metabolic panels to complex DNA analyses. Hospitals utilise these tests for patient diagnosis, monitoring, and therapy guidance. Moreover, IVDs' use has expanded beyond traditional settings, with point-of-care tests and self-testing kits gaining popularity for their convenience and rapid results.
Further, the growing adoption of personalised medicine in the region has led to an increased emphasis on in-vitro diagnostics as a key component in this approach. Personalised medicine aims to tailor treatments based on an individual's unique genetic makeup, necessitating the use of IVDs for genetic testing and biomarker identification. This trend, along with the technological advancements in genomics and proteomics, has made IVDs an integral part of precision medicine, thereby boosting the Latin America in-vitro diagnostics market share.
Moreover, the Latin America in-vitro diagnostics market is being further spurred by the increased investments in healthcare infrastructure and the growing focus on research and development in the field of diagnostic medicine. Governments and private organisations across the region are recognising the potential of IVD in enhancing healthcare delivery, leading to substantial funding and supportive policies that foster the market development.
Market Segmentation
The market can be divided based on product and service, technology, application, end use, and country.
Market Breakup by Product and Service
- Reagents and Kits
- Instruments
- Software and Services
Market Breakup by Technology
- Infectious Diseases
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked Immunospot (ELISPOT)
o Rapid Tests
o Radioimmunoassay (RIA)
o Western Blotting
o Others
- Clinical Chemistry
o Basic Metabolic Panels
o Liver Panels
o Renal Profiles
o Lipid Profiles
o Thyroid Function Panels
o Electrolyte Panels
o Speciality Chemical Tests
o Others
- Molecular Diagnostics
o Polymerise Chain Reaction (PCR)
o Isothermal Nucleic Acid Amplification Technology (INAAT)
o Hybridisation
o DNA Diagnostics
o Microarray
o Others
- Haematology
- Microbiology
- Coagulation and Haemostasis
- Urinalysis
- Others
Market Breakup by Application
- Infectious Diseases
- Diabetes
- Cardiology
- Oncology
- Drug Testing/Pharmacogenomics
- HIV/Aids
- Autoimmune Diseases
- Nephrology
- Others
Market Breakup by End Use
- Hospital and Clinics
- Diagnostic Laboratories
- Point-Of-Care Testing
- Academic Institutes
- Others
Market Breakup by Country
- Brazil
- Argentina
- Mexico
- Chile
- Peru
- Uruguay
- Others
Competitive Landscape
The EMR report looks into the market shares, plant turnarounds, capacities, investments, and mergers and acquisitions, among other major developments, of the leading companies operating in the Latin America in-vitro diagnostics market. Some of the major players explored in the report by Expert Market Research are as follows:
- F. Hoffmann-La Roche Ltd
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- bioMerieux SA
- WAMA Diagnostica
- Others
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provide the essential framework for organisations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organisation remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organisation's future success by acquiring one of our Expert Market Research reports today.
*We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

1 Preface
2 Report Coverage - Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Latin America
7 Opportunities and Challenges in the Market
8 Latin America In-Vitro Diagnostics Market Analysis
8.1 Key Industry Highlights
8.2 Latin America In-Vitro Diagnostics Historical Market (2018-2023)
8.3 Latin America In-Vitro Diagnostics Market Forecast (2024-2032)
8.4 Latin America In-Vitro Diagnostics Market by Product and Services
8.4.1 Reagents and Kits
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.2 Instruments
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.3 Software and Services
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.5 Latin America In-Vitro Diagnostics Market by Technology
8.5.1 Infectious Diseases
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.1.3 Breakup by Type
8.5.1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA)
8.5.1.3.2 Enzyme-Linked Immunospot (ELISPOT)
8.5.1.3.3 Rapid Tests
8.5.1.3.4 Radioimmunoassay (RIA)
8.5.1.3.5 Western Blotting
8.5.1.3.6 Others
8.5.2 Clinical Chemistry
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.2.3 Breakup by Type
8.5.2.3.1 Basic Metabolic Panels
8.5.2.3.2 Liver Panels
8.5.2.3.3 Renal Profiles
8.5.2.3.4 Lipid Profiles
8.5.2.3.5 Thyroid Function Panels
8.5.2.3.6 Electrolyte Panels
8.5.2.3.7 Specialty Chemical Tests
8.5.2.3.8 Others
8.5.3 Molecular Diagnostics
8.5.3.1 Historical Trend (2018-2023)
8.5.3.2 Forecast Trend (2024-2032)
8.5.3.3 Breakup by Type
8.5.3.3.1 Polymerize Chain Reaction (PCR)
8.5.3.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.5.3.3.3 Hybridisation
8.5.3.3.4 DNA Diagnostics
8.5.3.3.5 Microarray
8.5.3.3.6 Others
8.5.4 Haematology
8.5.4.1 Historical Trend (2018-2023)
8.5.4.2 Forecast Trend (2024-2032)
8.5.5 Microbiology
8.5.5.1 Historical Trend (2018-2023)
8.5.5.2 Forecast Trend (2024-2032)
8.5.6 Coagulation and Haemostasis
8.5.6.1 Historical Trend (2018-2023)
8.5.6.2 Forecast Trend (2024-2032)
8.5.7 Urinalysis
8.5.7.1 Historical Trend (2018-2023)
8.5.7.2 Forecast Trend (2024-2032)
8.5.8 Others
8.6 Latin America In-Vitro Diagnostics Market by Application
8.6.1 Infectious Diseases
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Diabetes
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Oncology
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.6.4 Cardiology
8.6.4.1 Historical Trend (2018-2023)
8.6.4.2 Forecast Trend (2024-2032)
8.6.5 Drug Testing/Pharmacogenomics
8.6.5.1 Historical Trend (2018-2023)
8.6.5.2 Forecast Trend (2024-2032)
8.6.6 HIV/Aids
8.6.6.1 Historical Trend (2018-2023)
8.6.6.2 Forecast Trend (2024-2032)
8.6.7 Autoimmune Diseases
8.6.7.1 Historical Trend (2018-2023)
8.6.7.2 Forecast Trend (2024-2032)
8.6.8 Nephrology
8.6.8.1 Historical Trend (2018-2023)
8.6.8.2 Forecast Trend (2024-2032)
8.6.9 Others
8.7 Latin America In-Vitro Diagnostics Market by End Use
8.7.1 Hospital and Clinics
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Diagnostic Laboratories
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Point-Of-Care Testing
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Academic Institutes
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Others
8.8 Latin America In-Vitro Diagnostics Market by Country
8.8.1 Brazil
8.8.2 Argentina
8.8.3 Mexico
8.8.4 Chile
8.8.5 Peru
8.8.6 Uruguay
8.8.7 Others
9 Regional Analysis
9.1 Brazil
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Argentina
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
9.3 Mexico
9.3.1 Historical Trend (2018-2023)
9.3.2 Forecast Trend (2024-2032)
9.4 Chile
9.4.1 Historical Trend (2018-2023)
9.4.2 Forecast Trend (2024-2032)
9.5 Peru
9.5.1 Historical Trend (2018-2023)
9.5.2 Forecast Trend (2024-2032)
9.6 Uruguay
9.6.1 Historical Trend (2018-2023)
9.6.2 Forecast Trend (2024-2032)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter's Five Forces Analysis
10.2.1 Supplier's Power
10.2.2 Buyer's Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Becton, Dickinson and Company
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Bio-Rad Laboratories, Inc.
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 bioMerieux SA
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 WAMA Diagnostica
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Others
12 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Latin America In-Vitro Diagnostics Market: Key Industry Highlights, 2018 and 2032
2. Latin America In-Vitro Diagnostics Historical Market: Breakup by Product and Services (USD Million), 2018-2023
3. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Product and Services (USD Million), 2024-2032
4. Latin America In-Vitro Diagnostics Historical Market: Breakup by Technology (USD Million), 2018-2023
5. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Technology (USD Million), 2024-2032
6. Latin America In-Vitro Diagnostics Historical Market: Breakup by Application (USD Million), 2018-2023
7. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Application (USD Million), 2024-2032
8. Latin America In-Vitro Diagnostics Historical Market: Breakup by End Use (USD Million), 2018-2023
9. Latin America In-Vitro Diagnostics Market Forecast: Breakup by End Use (USD Million), 2024-2032
10. Latin America In-Vitro Diagnostics Historical Market: Breakup by Country (USD Million), 2018-2023
11. Latin America In-Vitro Diagnostics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Latin America In-Vitro Diagnostics Market Structure.

  • Not Sure / Need Reassuring
    • Confirm Content
      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages
      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives
      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices
      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts
      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies
      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses
      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License
      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats
      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery
      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges
      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card
      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer
      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security
      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security
      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE